Consultant/Professor in Oral Medicine, Dublin Dental University Hospital, School of Dental Science, Trinity College Dublin, Ireland.
Consultant/Assistant Professor in Oral Medicine, Dublin Dental University Hospital, School of Dental Science, Trinity College Dublin, Ireland.
Br Dent J. 2024 Feb;236(4):317-321. doi: 10.1038/s41415-024-7065-9. Epub 2024 Feb 23.
Biologic drugs are drugs made by living organisms and the term is usually limited to monoclonal antibodies or receptors targeting specific cytokines or cells that have been developed in recent decades. These drugs have had an enormous impact on the management of cancers, including head and neck cancers, and immune-mediated inflammatory conditions, for example, rheumatoid arthritis and inflammatory bowel disease. General dental practitioners will routinely be managing patients who are on these medications for a wide range of systemic conditions. These drugs also have a limited role in the management of immune-mediated oral mucosal disease. In this article, we will introduce the range of biological agents and their systemic indications and then elaborate on their use in oral mucosal disease and the disadvantages associated with their use.
生物制剂是由生物体制造的药物,通常仅限于近几十年来开发的针对特定细胞因子或细胞的单克隆抗体或受体。这些药物对癌症的治疗产生了巨大的影响,包括头颈部癌症,以及免疫介导的炎症性疾病,如类风湿关节炎和炎症性肠病。普通牙科医生将经常管理因各种系统性疾病而正在服用这些药物的患者。这些药物在治疗免疫介导的口腔黏膜疾病方面也有一定的作用。在本文中,我们将介绍一系列生物制剂及其系统适应证,然后详细阐述它们在口腔黏膜疾病中的应用以及它们的应用相关的缺点。